The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
|Articles|July 26, 2011
The Ultrasound Detection of Chromosomal Anomalies
Adapted from "The Ultrasound Detection of Chromosomal Anomalies
Advertisement
Adapted from "The Ultrasound Detection of Chromosomal Anomalies-A multimedia Lecture"
by Philippe Jeanty. ISBN (0-9667878-0-3) available at
Note: some of the sections contain many images and may take some time to download
Findings in the second trimester
Advertisement
Related to this article
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA removes boxed warnings from 3 more menopausal hormone therapy products
2
Choosing Among Hormonal and Nonhormonal VMS Therapies in Menopause
3
Chrisandra Shufelt, MD, on cardiovascular prevention at menopause
4
Reactions to FDA's boxed warning removals for menopausal hormone therapy
5